Adam Keeney
Corporate Officer/Principal en BIOGEN INC. .
Fortuna: 148 910 $ al 31/05/2024
Cargos activos de Adam Keeney
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 17/04/2023 | - |
Historial de carrera de Adam Keeney
Antiguos cargos conocidos de Adam Keeney.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Director/Miembro de la Junta | 24/09/2018 | - |
| Director Ejecutivo | 24/09/2018 | - | |
| Presidente | 24/09/2018 | - |
Formación de Adam Keeney.
| The University of Nottingham | Doctorate Degree |
| University of Leeds | Undergraduate Degree |
Estadísticas
Internacional
| Reino Unido | 4 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Adam Keeney
- Experiencia
